Huntington National Bank’s MacroGenics MGNX Stock Holding History

Huntington National Bank’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-300	Closed	-$6K	–	1671
2015 Q3	$6K	Buy	+300	New	+$9.41K	﹤0.01%	1491

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Huntington National Bank's MGNX Position: Q4 2015 in Review

Huntington National Bank sold out of MacroGenics (MGNX) in Q4 2015, closing a stake of 300 shares — an estimated $6K sold.

Huntington National Bank first reported a position in MGNX in Q3 2015 and held it in 1 quarter. The position peaked at $6K in Q3 2015. 128 funds tracked by Wall St. Rank hold MGNX as of Q4 2015.

Huntington National Bank reported no remaining MacroGenics position as of Q4 2015 after selling out during the quarter.
Huntington National Bank sold 300 MacroGenics shares in Q4 2015, an estimated $6K.
Huntington National Bank first reported a position in MacroGenics in Q3 2015 and held it in 1 quarter.
Huntington National Bank's MacroGenics position peaked at $6K in Q3 2015.
128 funds tracked by Wall St. Rank held MacroGenics as of Q4 2015.

Based on Huntington National Bank's 13F filing for Q4 2015, filed 2 Feb 2016.